======= ALG11 =======
== Gene Information ==
* **Official Symbol**: ALG11
* **Official Name**: ALG11 alpha-1,2-mannosyltransferase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=440138|440138]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q2TAA5|Q2TAA5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ALG11&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ALG11|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613666|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase which is localized to the cytosolic side of the endoplasmic reticulum (ER) and catalyzes the transfer of the fourth and fifth mannose residue from GDP-mannose (GDP-Man) to Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol resulting in the production of Man5GlcNAc2-PP-dolichol. Mutations in this gene are associated with congenital disorder of glycosylation type Ip (CDGIP). This gene overlaps but is distinct from the UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast) gene. A pseudogene of the GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase has been identified on chromosome 19. [provided by RefSeq, Aug 2010].
* **UniProt Summary**: Mannosyltransferase involved in the last steps of the synthesis of Man5GlcNAc(2)-PP-dolichol core oligosaccharide on the cytoplasmic face of the endoplasmic reticulum. Catalyzes the addition of the 4th and 5th mannose residues to the dolichol- linked oligosaccharide chain. {ECO:0000269|PubMed:20080937}.
|Glycos transf 1|
|GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity|
|oligosaccharide-lipid intermediate biosynthetic process|
|mannosylation|
|protein N-linked glycosylation|
|protein glycosylation|
|macromolecule glycosylation|
|glycosylation|
|glycoprotein biosynthetic process|
|glycoprotein metabolic process|
|carbohydrate derivative biosynthetic process|
|endoplasmic reticulum membrane|
|cellular lipid metabolic process|
|carbohydrate derivative metabolic process|
|lipid metabolic process|
|organonitrogen compound biosynthetic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-1.78|
|[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|1.73|
|[[:results:exp33|Rotenone 2μM R00 exp33]]|1.78|
|[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|1.83|
|[[:results:exp19|Etoposide 1μM R00 exp19]]|1.93|
^Gene^Correlation^
|[[:human genes:h:hars|HARS]]|0.578|
|[[:human genes:c:cars|CARS]]|0.41|
|[[:human genes:c:ccdc101|CCDC101]]|0.403|
Global Fraction of Cell Lines Where Essential: 733/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|28/28|
|blood|28/28|
|bone|26/26|
|breast|33/33|
|central nervous system|55/56|
|cervix|4/4|
|colorectal|17/17|
|esophagus|13/13|
|fibroblast|1/1|
|gastric|16/16|
|kidney|21/21|
|liver|20/20|
|lung|74/75|
|lymphocyte|16/16|
|ovary|26/26|
|pancreas|24/24|
|peripheral nervous system|16/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|8/9|
|thyroid|2/2|
|upper aerodigestive|22/22|
|urinary tract|28/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 673
* **Expression level (log2 read counts)**: 5.92
{{:chemogenomics:nalm6 dist.png?nolink |}}